Asymmetric dimethylarginine: A disease marker for asthma?

Chest

Volumn 144, Issue 2, 2013, Pages 367-368

  Scott, Jeremy A ^a   Grasemann, Hartmut ^b  

^a LAKEHEAD UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LONG ACTING DRUG; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ASTHMA; BRONCHUS HYPERREACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; ENZYME ACTIVITY; ENZYME SUBSTRATE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; N(G),N(G) DIMETHYLARGININE BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

EID: 84881486056     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0480     Document Type: Editorial

References (11)

1. Barnes PJ, Dweik RA, Gelb AF, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010; 138 (3): 682-692.
2. Maarsingh H, Zaagsma J, Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol. 2009; 158 (3): 652-664.
3. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol. 2009; 296 (6): L911-L920.
4. North ML, Meurs H, Zaagsma J, Scott JA, Maarsingh H. Arginase in asthma-recent developments in animal and human studies. The Open Nitric Oxide Journal. 2010; 2: 20-36.
5. North ML, Grasemann H, Khanna N, Inman MD, Gauvreau GM, Scott JA. Increased ornithine-derived polyamines cause airways hyperresponsiveness in asthma [published online ahead of print March 7, 2013]. Am J Respir Cell Mol Biol. doi: 10.1165/rcmb.2012-0323OC.
6. Scott JA, North ML, Rafi i M, et al. Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med. 2011; 184 (7): 779-785.
7. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med. 2004; 170 (2): 148-153.
8. Lara A, Khatri SB, Wang Z, et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med. 2008; 178 (7): 673-681.
9. Holguin F, Comhair SA, Hazen SL, et al. An association between (L)-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med. 2013; 187 (2): 153-159.
10. Carraro S, Giordano G, Piacentini G, et al. Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. Chest. 2013; 144 (2): 405-410.
11. Corradi M, Zinelli C, Caffarelli C. Exhaled breath biomarkers in asthmatic children. Infl amm Allergy Drug Targets. 2007; 6 (3): 150-159.